Greenyn Biotechnology Co., Ltd (6846.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$58.80 (+1.55%) as of
Key statistics
- Market cap
- 1.59B
- P/E (TTM)
- 14.59
- Forward P/E
- 9.98
- EPS (TTM)
- 4.03
- Dividend yield
- 6.81%
- 52-week range
- 55.60 – 78.00
- Profit margin
- 0.00%
- Volume
- 13.44k
About Greenyn Biotechnology Co., Ltd
Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for youth and beauty series, digestive health series, brain health series, body regulation series, throat moistening series, hair care series, clear eye series, colorful lifestyle series, joint health series, nutritional supplement series, energy supplement series, immune modulation series, low burden series, sleep aid series, body curve series, circulation series, man power series, women's intimate health series, and mature woman series. In addition, the company offers customization, ODM, dosage, and application services. Greenyn Biotechnology Co., Ltd was founded in 2012 and is based in Taichung, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Taichung, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.